Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/187152008783330824PMID 18220506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

  2007cited by this paper
• An ELISA method for the detection and quantification of human heparanase.

  2006cited by this paper
• VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase*

  2006cited by this paper
• A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.

  2006cited by this paper
• The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.

  2006cited by this paper
• Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies.

  2006cited by this paper
• Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells

  2006cited by this paper
• Interactions between heparan sulfate and proteins: the concept of specificity

  2006cited by this paper
• Mutations in the waaR Gene of Escherichia coli Which Disrupt Lipopolysaccharide Outer Core Biosynthesis Affect Cell Surface Retention of Group 2 Capsular Polysaccharides

  2006cited by this paper
• N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

  2006cited by this paper
• Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

  2005cited by this paper
• Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting*

  2005cited by this paper
• Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells.

  2005cited by this paper
• Basement membrane proteoglycans: from cellar to ceiling

  2005cited by this paper
• In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

  2005cited by this paper
• Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies.

  2005cited by this paper
• Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells*

  2005cited by this paper
• Mice deficient in Ext2 lack heparan sulfate and develop exostoses

  2005cited by this paper
• Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host?

  2005cited by this paper
• The sweet and sour of cancer: glycans as novel therapeutic targets

  2005cited by this paper
• Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor.

  2005cited by this paper
• Heparan sulfate: a complex polymer charged with biological activity.

  2005cited by this paper
• Generation of "neoheparin" from E. coli K5 capsular polysaccharide.

  2005cited by this paper
• Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

  2005cited by this paper
• Decreased expression of heparanase in glioblastoma multiforme.

  2005cited by this paper
• Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

  2005cited by this paper
• Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

  2004cited by this paper
• Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production*

  2004cited by this paper
• Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.

  2004cited by this paper
• Regulation of angiogenesis by extracellular matrix.

  2004cited by this paper
• Characterization of Growth Factor-binding Structures in Heparin/Heparan Sulfate Using an Octasaccharide Library*

  2004cited by this paper
• Functions of heparan sulfate proteoglycans in cell signaling during development

  2004cited by this paper
• Antiangiogenic Activity of Semisynthetic Biotechnological Heparins: Low-Molecular-Weight–Sulfated Escherichia coli K5 Polysaccharide Derivatives as Fibroblast Growth Factor Antagonists

  2004cited by this paper
• Stem domains of heparan sulfate 6-O-sulfotransferase are required for Golgi localization, oligomer formation and enzyme activity

  2004cited by this paper
• Processing and activation of latent heparanase occurs in lysosomes

  2004cited by this paper
• Novel aspects of glypican glycobiology

  2004cited by this paper
• Ultrafiltration-based assay for heparanase activity.

  2004cited by this paper
• Heparanase Uptake Is Mediated by Cell Membrane Heparan Sulfate Proteoglycans*

  2004cited by this paper
• Low-molecular-weight heparin in thrombosis and cancer.

  2004cited by this paper
• Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.

  2004cited by this paper
• Undersulfated and glycol-split heparins endowed with antiangiogenic activity.

  2004cited by this paper
• A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer

  2004cited by this paper
• Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.

  2004cited by this paper
• Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

  2004cited by this paper
• High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents.

  2004cited by this paper
• In Vitro Polymerization of Heparan Sulfate Backbone by the EXT Proteins*

  2003cited by this paper
• Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide

  2003cited by this paper
• Role of the extracellular matrix in morphogenesis.

  2003cited by this paper
• Heparanase mediates cell adhesion independent of its enzymatic activity

  2003cited by this paper
• Processing of Macromolecular Heparin by Heparanase*

  2003cited by this paper
• Targeted Disruption of a Murine Glucuronyl C5-epimerase Gene Results in Heparan Sulfate Lacking l-Iduronic Acid and in Neonatal Lethality*

  2003cited by this paper
• Heterodimer formation is essential for heparanase enzymatic activity.

  2003cited by this paper
• Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology.

  2003cited by this paper
• Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly

  2003cited by this paper
• QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling

  2003cited by this paper
• Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

  2003cited by this paper
• The extracellular matrix as a scaffold for tissue reconstruction.

  2002cited by this paper
• Heparin and Heparan Sulfate Biosynthesis

  2002cited by this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cited by this paper
• Organogenesis: Molecular Mechanisms Of Tubulogenesis

  2002cited by this paper
• Structural Recognition by Recombinant Human Heparanase That Plays Critical Roles in Tumor Metastasis

  2002cited by this paper
• Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development

  2002cited by this paper
• Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors.

  2002cited by this paper
• Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

  2001cited by this paper
• Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

  2001cited by this paper
• Characterization of the d-Glucuronyl C5-epimerase Involved in the Biosynthesis of Heparin and Heparan Sulfate*

  2001cited by this paper
• Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2*

  2001cited by this paper
• Heparanase: a key enzyme involved in cell invasion.

  2001cited by this paper
• Expression Pattern and Secretion of Human and Chicken Heparanase Are Determined by Their Signal Peptide Sequence*

  2001cited by this paper
• Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.

  2001cited by this paper
• Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.

  2001cited by this paper
• Proteoglycans of the extracellular matrix and growth control

  2001cited by this paper
• Role of heparan sulfate in fibroblast growth factor signalling: a structural view.

  2001cited by this paper
• Heparan sulfate: growth control with a restricted sequence menu.

  2001cited by this paper
• Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

  2000cited by this paper
• Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.

  2000cited by this paper
• Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.

  2000cited by this paper
• Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

  2000cited by this paper
• Defective Heparan Sulfate Biosynthesis and Neonatal Lethality in Mice LackingN-Deacetylase/N-Sulfotransferase-1*

  2000cited by this paper
• Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

  2000cited by this paper
• Heparanase, a potential regulator of cell-matrix interactions.

  2000cited by this paper
• Prognosis of cancers associated with venous thromboembolism.

  2000cited by this paper
• Genomic organization and chromosome localization of the newly identified human heparanase gene.

  2000cited by this paper
• Heparanase: Breaking down barriers in tumors

  1999cited by this paper
• Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

  1999cited by this paper
• Heparin Is a Unique Marker of Progenitors in the Glial Cell Lineage*

  1999cited by this paper
• Functions of cell surface heparan sulfate proteoglycans.

  1999cited by this paper
• Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

  1999cited by this paper
• Synthesis of thrombin-inhibiting heparin mimetics without side effects

  1999cited by this paper
• Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.

  1999cited by this paper
• Multiple Isoforms of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase

  1999cited by this paper
• Heparan Sulfate Mediates bFGF Transport through Basement Membrane by Diffusion with Rapid Reversible Binding*

  1999cited by this paper
• Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

  1999cited by this paper
• The Effects of Unfractionated Heparin on Survival in Patients with Malignancy – A Systematic Review

  1999cited by this paper
• Human Heparanase

  1999cited by this paper
• Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase.

  1998cited by this paper
• Matrix proteoglycans: from molecular design to cellular function.

  1998cited by this paper
• Substrate Specificity of Heparanases from Human Hepatoma and Platelets*

  1998cited by this paper
• Structure and biological activity of the extracellular matrix

  1998cited by this paper
• A sugar fix for bone tumours?

  1998cited by this paper

• Evaluation of the Recombinant Bacterial Chitinases as Anti-proliferative and Anti-migratory Agents for the Human Breast Cancer Cell Line, MCF-7

  2024cites this paper
• The mechanisms underlying the enrichment and action of glypican-1-positive exosomes in colorectal cancer cells.

  2023cites this paper
• Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo

  2023cites this paper
• Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer

  2022cites this paper
• Biomimetic sulfated glycosaminoglycans maintain differentiation markers of breast epithelial cells and preferentially inhibit proliferation of cancer cells.

  2021cites this paper
• Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives.

  2020cites this paper
• COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

  2020cites this paper
• Hereditary multiple exostoses complicated with lung cancer with cough as the first symptom: a case report

  2020cites this paper
• Heparanase Inhibitors in Cancer Progression: Recent Advances.

  2020cites this paper
• Proteoglycans as miscommunication biomarkers for cancer diagnosis.

  2019cites this paper
• Chondroitin, Dermatan, Heparan, and Keratan Sulfate: Structure and Functions

  2019cites this paper
• Factor Analysis for Bicluster Acquisition (FABIA) revealed vincristine-sensitive transcript pattern of canine transmissible venereal tumors

  2019cites this paper
• Demystifying the pH dependent conformational changes of human heparanase pertaining to structure–function relationships: an in silico approach

  2018cites this paper
• The Extracellular Matrix as a Target for Biophysical and Molecular Magnetic Resonance Imaging

  2018cites this paper
• Heparan sulfate dependent cell signaling and associated pathophysiology : Implications in tumorigenesis and embryogenesis

  2018influential citation
• Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase

  2017cites this paper
• Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways

  2017cites this paper
• Newly uncovered novel properties of heparanase in the heart and pancreas

  2016cites this paper
• Expression of heparanase in basal cell carcinoma and squamous cell carcinoma*

  2016cites this paper
• Lysosome and Cancer

  2016cites this paper
• Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate

  2016cites this paper
• Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma

  2015cites this paper
• The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.

  2015cites this paper
• Pharmacokinetics of low molecular weight heparin in patients with malignant tumors

  2015cites this paper
• Administration of low molecular weight heparins for prolonging the survival of patients with cancer

  2015cites this paper
• Importance des glycosaminoglycanes de surface dans les phénomènes inflammatoires liés au cancer

  2014cites this paper
• Combination therapy with low molecular weight heparin and Adriamycin results in decreased breast cancer cell metastasis in C3H mice

  2014cites this paper
• Expression of Heparanase Is Associated with Breed-Specific Morphological Characters of Placental Folded Bilayer Between Yorkshire and Meishan Pigs1

  2014cites this paper
• The exostosin family: proteins with many functions.

  2014cites this paper
• Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.

  2014cites this paper
• Syndecan - Regulation and Function of its Glycosaminoglycan Chains

  2013cites this paper
• IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy.

  2013cites this paper
• Development of Novel Inhibitors Specific for Human Heparanase-1

  2013cites this paper
• Over-sulfated glycosaminoglycans are alternative selectin ligands: insights into molecular interactions and possible role in breast cancer metastasis

  2013cites this paper
• Cancer-associated lysosomal changes: friends or foes?

  2013cites this paper
• Fibroblast EXT1-Levels Influence Tumor Cell Proliferation and Migration in Composite Spheroids

  2012influential citation
• Tandem Mass Spectrometry of Heparan Sulfate Negative Ions: Sulfate Loss Patterns and Chemical Modification Methods for Improvement of Product Ion Profiles

  2012cites this paper
• Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?

  2011cites this paper
• Interleukin-2 is Present in Human Blood Vessels and Released in Biologically Active Form by Heparanase

  2011cites this paper
• Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma.

  2011cites this paper
• Syntheses of novel azasugar-containing mimics of heparan sulfate fragments as potential heparanase inhibitors.

  2010cites this paper
• Molecular Structure of Heparan Sulfate from Spalax

  2009cites this paper
• The Effect of LMWH (Nadroparin) on Tumor Progression

  2009cites this paper
• The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment.

  2009cites this paper
• Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence

  2009cites this paper
• Anti-Metastatic Activities of Heparins

  2009cites this paper
• Heparanase and its related molecules in odontogenic tumors

  2009cites this paper
• Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism*

  2008cites this paper
• Pathway Targets to Explore in the Treatment of Non-small Cell Lung Cancer

  2008cites this paper
• Targeting heparan sulfate proteoglycans in breast cancer treatment.

  2008cites this paper
• Lysosomes

  1966cites this paper
• Molecular biological characteristics of hereditary multiple exostoses

  year unknowncites this paper
• Acta Universitatis Upsaliensis Uppsala 2011 List of Papers

  year unknowncites this paper